From Pilots to P&L: Making AI Show Real ROI in Commercial Numbers
About this Event
Commercial teams across pharma and biotech are investing heavily in AI, from next-best-action to forecasting, but as 2027 planning begins, the pressure to show measurable returns is rising. Join Catalant's CEO Pat Petitti and a small group of C-suite and VP-level commercial leaders for an intimate conversation about what’s actually working, where pilots are stalling, and how leaders are tying AI investments to results the business can see. Join us for dinner and candid conversation at the lovely Contessa restaurant on Newbury Street.
Where is it happening?
Event Location & Nearby Stays:
USD 0.00

















